SpectRx, Inc. Schedules Date for Release of Third Quarter 2004 Results

SpectRx, Inc. Schedules Date for Release of Third Quarter 2004
Results 


NORCROSS, Ga., Nov. 4  /PRNewswire-FirstCall/ -- SpectRx, Inc. (OTC:SPRX)
(BULLETIN BOARD: SPRX)  announced today that it plans to release third quarter
2004 results after the market closes on Wednesday, November 10, 2004. SpectRx
will host a conference call and webcast to review the Company's financial
results on Thursday, November 11, 2004 at 11:30 a.m. Eastern Time.

The webcast will be made available at http://www.fulldisclosure.com/ or
http://www.ccbn.com/ .  The telephone number to participate in the conference
call is 800-889-0817.  A replay of the conference call will be made available
until November 17, 2004, by dialing 800-642-1687, passcode 2051502.

About SpectRx

SpectRx, Inc. (OTC:SPRX) (BULLETIN BOARD: SPRX)  is a diabetes management
company developing and providing innovative solutions for insulin delivery and
glucose monitoring.  SpectRx markets the SimpleChoice(R) line of innovative
diabetes management products, which include insulin pump disposable supplies. 
SpectRx also plans to develop a consumer device for continuous glucose
monitoring. The company is commercializing its non-invasive cancer detection
technology through subsidiary company Guided Therapeutics, Inc, which SpectRx
intends to separately finance with private funds.  For more information, visit
SpectRx's web sites at spectrx.com, mysimplechoice.com and
guidedtherapeutics.com . 

DATASOURCE: SpectRx, Inc.



CONTACT: Media, Bill Wells, or Financial, Thomas H. Muller, Jr., of

SpectRx, Inc., [phone]



Web site:  http://www.spectrx.com/

http://www.mysimplechoice.com/

http://www.guidedtherapeutics.com/

http://www.fulldisclosure.com/

http://www.ccbn.com/ 

Copyright